The overall objective of this study is to pilot the VASDHS-adapted Emory MDMA-PE Protocol
(aE-MDMA-PE) and assess the effect on clinician-rated PTSD symptoms in veterans who receive
full-dose MDMA and veterans who receive low-dose MDMA.
Phase:
Phase 3
Details
Lead Sponsor:
Healing Breakthrough
Collaborators:
Lykos Therapeutics National Center for PTSD San Diego Veterans Healthcare System White River Junction VA Medical Center